Hybrigenics has extended its partnership with Servier to discover new drugs which inhibit Ubiquitin-Specific Proteases, or USPs. This partnership was initiated in October 2011.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0097 EUR | -2.02% |
|
-2.02% | -56.31% |
Jun. 04 | ITALY GROWTH WINNERS & LOSERS: Bullish plants; Aton Green at the back of the pack. | AN |
May. 07 | ATON board of directors chooses Uguzzoni as CEO and appoints Nervosi as vice chairman | AN |
1st Jan change | Capi. | |
---|---|---|
-56.31% | 4.28M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.33% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- ALHYG Stock
- News ATON
- Hybrigenics Extends Partnership with Servier for USPs Inhibitors